Oxford Nanopore Technologies plc (LON:ONT)
117.90
+0.30 (0.26%)
Apr 17, 2025, 4:39 PM BST
LON:ONT Revenue
In the year 2024, Oxford Nanopore Technologies had annual revenue of 183.19M GBP with 7.97% growth. Oxford Nanopore Technologies had revenue of 99.11M in the half year ending December 31, 2024, with 29.97% growth.
Revenue
183.19M
Revenue Growth
+7.97%
P/S Ratio
6.15
Revenue / Employee
139.31K
Employees
1,315
Market Cap
1.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 183.19M | 13.52M | 7.97% |
Dec 31, 2023 | 169.67M | -28.94M | -14.57% |
Dec 31, 2022 | 198.60M | 64.94M | 48.59% |
Dec 31, 2021 | 133.66M | 19.80M | 17.39% |
Dec 31, 2020 | 113.86M | 61.80M | 118.70% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Oxford Nanopore Technologies News
- 3 days ago - Breakthrough algorithm enables partially phased, near telomere-to-telomere assembly using standard Oxford Nanopore Simplex reads - Business Wire
- 7 days ago - Oxford Nanopore Expands Compatible Products Programme and Strengthens Multi-Omics Ecosystem - Business Wire
- 6 weeks ago - Oxford Nanopore Technologies plc (ONTTF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - UK Stock Market News: Greggs, Beazley, Oxford Nanopore - The Armchair Trader
- 3 months ago - UK Stock Market News: PageGroup, Oxford Nanopore, Entain - The Armchair Trader
- 5 months ago - Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease - Business Wire
- 5 months ago - UK health agencies join with Oxford Nanopore to speed up pathogen screening - Financial Times
- 5 months ago - Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK - Business Wire